How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Buy
52
COO Quote, Financials, Valuation and Earnings
Last price:
$79.83
Seasonality move
:
2.52%
Day range:
$78.59 - $80.04
52-week range:
$69.81 - $112.38
Dividend yield:
0%
P/E ratio:
38.73x
P/S ratio:
4.08x
P/B ratio:
1.96x
Volume:
2.2M
Avg. volume:
2.3M
1-year change:
-11.38%
Market cap:
$16B
Revenue:
$3.9B
EPS (TTM):
$2.06
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$980.9M | $0.91 | 5.65% | 111.18% | $105.55 |
|
ALGN
Align Technology
|
$975M | $1.99 | -1.71% | 44.8% | $234.70 |
|
KIDS
OrthoPediatrics
|
$51.7M | -$0.44 | 16.61% | -15.39% | $37.57 |
|
LUCY
Innovative Eyewear
|
$1M | -$0.73 | 160.78% | -75.67% | $9.00 |
|
NXGL
NexGel
|
$2.7M | -$0.10 | 115.25% | -28.57% | $6.00 |
|
STAA
Staar Surgical
|
$40.3M | -$0.60 | -47.87% | -731.74% | $18.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$79.79 | $105.55 | $16B | 38.73x | $0.01 | 0% | 4.08x |
|
ALGN
Align Technology
|
$173.87 | $234.70 | $12.8B | 30.99x | $0.00 | 0% | 3.26x |
|
KIDS
OrthoPediatrics
|
$20.76 | $37.57 | $515.5M | -- | $0.00 | 0% | 2.34x |
|
LUCY
Innovative Eyewear
|
$1.77 | $9.00 | $5.4M | -- | $0.00 | 0% | 1.59x |
|
NXGL
NexGel
|
$2.76 | $6.00 | $18.7M | -- | $0.00 | 0% | 2.07x |
|
STAA
Staar Surgical
|
$17.17 | $18.50 | $846.9M | 49.73x | $0.00 | 0% | 2.70x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
COO
The Cooper Companies
|
23.79% | 1.443 | 13.14% | 0.82x |
|
ALGN
Align Technology
|
-- | 2.064 | -- | 1.02x |
|
KIDS
OrthoPediatrics
|
17.1% | -0.108 | 13.02% | 3.27x |
|
LUCY
Innovative Eyewear
|
-- | 12.658 | -- | 10.38x |
|
NXGL
NexGel
|
10.64% | 0.331 | 2.24% | 1.11x |
|
STAA
Staar Surgical
|
-- | 0.150 | -- | 4.41x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$660.2M | $182M | 3.93% | 5.24% | 18.59% | $101.2M |
|
ALGN
Align Technology
|
$696.9M | $177.1M | 11.12% | 11.12% | 17.79% | $263.1M |
|
KIDS
OrthoPediatrics
|
$35.6M | -$8.6M | -9.36% | -10.25% | -10.07% | -$3.7M |
|
LUCY
Innovative Eyewear
|
$93.7K | -$2.2M | -105.44% | -105.44% | -307.83% | -$2M |
|
NXGL
NexGel
|
$779K | -$841K | -54.64% | -63.18% | -26.64% | -$928K |
|
STAA
Staar Surgical
|
$31.6M | -$27.9M | -5.02% | -5.02% | -57.02% | -$5.1M |
The Cooper Companies vs. Competitors
-
Which has Higher Returns COO or ALGN?
Align Technology has a net margin of 10.81% compared to The Cooper Companies's net margin of 10.43%. The Cooper Companies's return on equity of 5.24% beat Align Technology's return on equity of 11.12%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies68.44% $0.52 $10.7B ALGNAlign Technology70.03% $1.39 $3.9B -
What do Analysts Say About COO or ALGN?
The Cooper Companies has a consensus price target of $105.55, signalling upside risk potential of 32.29%. On the other hand Align Technology has an analysts' consensus of $234.70 which suggests that it could grow by 34.99%. Given that Align Technology has higher upside potential than The Cooper Companies, analysts believe Align Technology is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 6 0 ALGNAlign Technology9 5 0 -
Is COO or ALGN More Risky?
The Cooper Companies has a beta of 1.007, which suggesting that the stock is 0.692% more volatile than S&P 500. In comparison Align Technology has a beta of 1.728, suggesting its more volatile than the S&P 500 by 72.834%.
-
Which is a Better Dividend Stock COO or ALGN?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Align Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Align Technology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or ALGN?
The Cooper Companies quarterly revenues are $964.7M, which are smaller than Align Technology quarterly revenues of $995.2M. The Cooper Companies's net income of $104.3M is higher than Align Technology's net income of $103.8M. Notably, The Cooper Companies's price-to-earnings ratio is 38.73x while Align Technology's PE ratio is 30.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.08x versus 3.26x for Align Technology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.08x 38.73x $964.7M $104.3M ALGNAlign Technology3.26x 30.99x $995.2M $103.8M
-
Which has Higher Returns COO or KIDS?
OrthoPediatrics has a net margin of 10.81% compared to The Cooper Companies's net margin of -30.51%. The Cooper Companies's return on equity of 5.24% beat OrthoPediatrics's return on equity of -10.25%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies68.44% $0.52 $10.7B KIDSOrthoPediatrics67.53% -$0.69 $427.7M -
What do Analysts Say About COO or KIDS?
The Cooper Companies has a consensus price target of $105.55, signalling upside risk potential of 32.29%. On the other hand OrthoPediatrics has an analysts' consensus of $37.57 which suggests that it could grow by 80.98%. Given that OrthoPediatrics has higher upside potential than The Cooper Companies, analysts believe OrthoPediatrics is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 6 0 KIDSOrthoPediatrics3 1 0 -
Is COO or KIDS More Risky?
The Cooper Companies has a beta of 1.007, which suggesting that the stock is 0.692% more volatile than S&P 500. In comparison OrthoPediatrics has a beta of 1.166, suggesting its more volatile than the S&P 500 by 16.642%.
-
Which is a Better Dividend Stock COO or KIDS?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. OrthoPediatrics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. OrthoPediatrics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or KIDS?
The Cooper Companies quarterly revenues are $964.7M, which are larger than OrthoPediatrics quarterly revenues of $52.7M. The Cooper Companies's net income of $104.3M is higher than OrthoPediatrics's net income of -$16.1M. Notably, The Cooper Companies's price-to-earnings ratio is 38.73x while OrthoPediatrics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.08x versus 2.34x for OrthoPediatrics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.08x 38.73x $964.7M $104.3M KIDSOrthoPediatrics2.34x -- $52.7M -$16.1M
-
Which has Higher Returns COO or LUCY?
Innovative Eyewear has a net margin of 10.81% compared to The Cooper Companies's net margin of -307.83%. The Cooper Companies's return on equity of 5.24% beat Innovative Eyewear's return on equity of -105.44%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies68.44% $0.52 $10.7B LUCYInnovative Eyewear13.57% -$0.87 $9.1M -
What do Analysts Say About COO or LUCY?
The Cooper Companies has a consensus price target of $105.55, signalling upside risk potential of 32.29%. On the other hand Innovative Eyewear has an analysts' consensus of $9.00 which suggests that it could grow by 408.48%. Given that Innovative Eyewear has higher upside potential than The Cooper Companies, analysts believe Innovative Eyewear is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 6 0 LUCYInnovative Eyewear0 0 0 -
Is COO or LUCY More Risky?
The Cooper Companies has a beta of 1.007, which suggesting that the stock is 0.692% more volatile than S&P 500. In comparison Innovative Eyewear has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or LUCY?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Innovative Eyewear offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Innovative Eyewear pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or LUCY?
The Cooper Companies quarterly revenues are $964.7M, which are larger than Innovative Eyewear quarterly revenues of $690.7K. The Cooper Companies's net income of $104.3M is higher than Innovative Eyewear's net income of -$2.1M. Notably, The Cooper Companies's price-to-earnings ratio is 38.73x while Innovative Eyewear's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.08x versus 1.59x for Innovative Eyewear. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.08x 38.73x $964.7M $104.3M LUCYInnovative Eyewear1.59x -- $690.7K -$2.1M
-
Which has Higher Returns COO or NXGL?
NexGel has a net margin of 10.81% compared to The Cooper Companies's net margin of -27.95%. The Cooper Companies's return on equity of 5.24% beat NexGel's return on equity of -63.18%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies68.44% $0.52 $10.7B NXGLNexGel25.62% -$0.11 $6.8M -
What do Analysts Say About COO or NXGL?
The Cooper Companies has a consensus price target of $105.55, signalling upside risk potential of 32.29%. On the other hand NexGel has an analysts' consensus of $6.00 which suggests that it could grow by 117.39%. Given that NexGel has higher upside potential than The Cooper Companies, analysts believe NexGel is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 6 0 NXGLNexGel0 0 0 -
Is COO or NXGL More Risky?
The Cooper Companies has a beta of 1.007, which suggesting that the stock is 0.692% more volatile than S&P 500. In comparison NexGel has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or NXGL?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. NexGel pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or NXGL?
The Cooper Companies quarterly revenues are $964.7M, which are larger than NexGel quarterly revenues of $3M. The Cooper Companies's net income of $104.3M is higher than NexGel's net income of -$850K. Notably, The Cooper Companies's price-to-earnings ratio is 38.73x while NexGel's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.08x versus 2.07x for NexGel. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.08x 38.73x $964.7M $104.3M NXGLNexGel2.07x -- $3M -$850K
-
Which has Higher Returns COO or STAA?
Staar Surgical has a net margin of 10.81% compared to The Cooper Companies's net margin of -69.92%. The Cooper Companies's return on equity of 5.24% beat Staar Surgical's return on equity of -5.02%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies68.44% $0.52 $10.7B STAAStaar Surgical64.65% -$0.69 $397.3M -
What do Analysts Say About COO or STAA?
The Cooper Companies has a consensus price target of $105.55, signalling upside risk potential of 32.29%. On the other hand Staar Surgical has an analysts' consensus of $18.50 which suggests that it could grow by 7.75%. Given that The Cooper Companies has higher upside potential than Staar Surgical, analysts believe The Cooper Companies is more attractive than Staar Surgical.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 6 0 STAAStaar Surgical3 10 1 -
Is COO or STAA More Risky?
The Cooper Companies has a beta of 1.007, which suggesting that the stock is 0.692% more volatile than S&P 500. In comparison Staar Surgical has a beta of 0.747, suggesting its less volatile than the S&P 500 by 25.297%.
-
Which is a Better Dividend Stock COO or STAA?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Staar Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Staar Surgical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or STAA?
The Cooper Companies quarterly revenues are $964.7M, which are larger than Staar Surgical quarterly revenues of $49M. The Cooper Companies's net income of $104.3M is higher than Staar Surgical's net income of -$34.2M. Notably, The Cooper Companies's price-to-earnings ratio is 38.73x while Staar Surgical's PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.08x versus 2.70x for Staar Surgical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.08x 38.73x $964.7M $104.3M STAAStaar Surgical2.70x 49.73x $49M -$34.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 34x
Alerts
Buy
56
ROOT alert for Apr 23
Root [ROOT] is up 13.93% over the past day.
Buy
72
EFX alert for Apr 23
Equifax [EFX] is up 13.86% over the past day.
Buy
51
CALX alert for Apr 23
Calix [CALX] is up 13.26% over the past day.
